These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 10087185)
1. Decreased proteasome-mediated degradation in T cells from the elderly: A role in immune senescence. Ponnappan U; Zhong M; Trebilcock GU Cell Immunol; 1999 Mar; 192(2):167-74. PubMed ID: 10087185 [TBL] [Abstract][Full Text] [Related]
2. Studies into the effect of tyrosine phosphatase inhibitor phenylarsine oxide on NFkappaB activation in T lymphocytes during aging: evidence for altered IkappaB-alpha phosphorylation and degradation. Ponnappan U; Trebilcock GU; Zheng MZ Exp Gerontol; 1999 Jan; 34(1):95-107. PubMed ID: 10197731 [TBL] [Abstract][Full Text] [Related]
3. Tyrosine phosphorylation-dependent activation of NFkappaB is compromised in T cells from the elderly. Ponnappan S; Uken-Trebilcock G; Lindquist M; Ponnappan U Exp Gerontol; 2004 Apr; 39(4):559-66. PubMed ID: 15050291 [TBL] [Abstract][Full Text] [Related]
4. Activation of NF-kappa B/Rel by Tax involves degradation of I kappa B alpha and is blocked by a proteasome inhibitor. Maggirwar SB; Harhaj E; Sun SC Oncogene; 1995 Sep; 11(5):993-8. PubMed ID: 7675460 [TBL] [Abstract][Full Text] [Related]
5. Transient nuclear factor kappaB (NF-kappaB) activation stimulated by interleukin-1beta may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IkappaBalpha molecule, in C6 glioma cells. Regulation of NF-kappaB linked to chemokine production. Uehara T; Matsuno J; Kaneko M; Nishiya T; Fujimuro M; Yokosawa H; Nomura Y J Biol Chem; 1999 May; 274(22):15875-82. PubMed ID: 10336492 [TBL] [Abstract][Full Text] [Related]
7. Bcl-2 activates the transcription factor NFkappaB through the degradation of the cytoplasmic inhibitor IkappaBalpha. de Moissac D; Mustapha S; Greenberg AH; Kirshenbaum LA J Biol Chem; 1998 Sep; 273(37):23946-51. PubMed ID: 9727009 [TBL] [Abstract][Full Text] [Related]
8. Redox regulation of the proteasome in T lymphocytes during aging. Das R; Ponnappan S; Ponnappan U Free Radic Biol Med; 2007 Feb; 42(4):541-51. PubMed ID: 17275686 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor. Hellerbrand C; Jobin C; Iimuro Y; Licato L; Sartor RB; Brenner DA Hepatology; 1998 May; 27(5):1285-95. PubMed ID: 9581682 [TBL] [Abstract][Full Text] [Related]
11. Proteasome regulation of Fas ligand cytotoxicity. Matsui K; Omura S; Cui H; Schauer SL; Sonenshein GE; Ju ST Eur J Immunol; 1997 Sep; 27(9):2269-78. PubMed ID: 9341769 [TBL] [Abstract][Full Text] [Related]
12. Ubiquitin-proteasome inhibition enhances apoptosis of human pancreatic cancer cells. McDade TP; Perugini RA; Vittimberga FJ; Callery MP Surgery; 1999 Aug; 126(2):371-7. PubMed ID: 10455908 [TBL] [Abstract][Full Text] [Related]
13. Essential role of human leukocyte antigen-encoded proteasome subunits in NF-kappaB activation and prevention of tumor necrosis factor-alpha-induced apoptosis. Hayashi T; Faustman D J Biol Chem; 2000 Feb; 275(7):5238-47. PubMed ID: 10671572 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132. Fiedler MA; Wernke-Dollries K; Stark JM Am J Respir Cell Mol Biol; 1998 Aug; 19(2):259-68. PubMed ID: 9698598 [TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-proteasome pathway is compromised in CD45RO+ and CD45RA+ T lymphocyte subsets during aging. Ponnappan U Exp Gerontol; 2002; 37(2-3):359-67. PubMed ID: 11772523 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide. Gao Y; Lecker S; Post MJ; Hietaranta AJ; Li J; Volk R; Li M; Sato K; Saluja AK; Steer ML; Goldberg AL; Simons M J Clin Invest; 2000 Aug; 106(3):439-48. PubMed ID: 10930447 [TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibition leads to NF-kappaB-independent IL-8 transactivation in human endothelial cells through induction of AP-1. Hipp MS; Urbich C; Mayer P; Wischhusen J; Weller M; Kracht M; Spyridopoulos I Eur J Immunol; 2002 Aug; 32(8):2208-17. PubMed ID: 12209633 [TBL] [Abstract][Full Text] [Related]
18. Nuclear factor-kappaB induction in CD45RO+ and CD45RA+ T cell subsets during aging. Trebilcock GU; Ponnappan U Mech Ageing Dev; 1998 May; 102(2-3):149-63. PubMed ID: 9720648 [TBL] [Abstract][Full Text] [Related]
19. Association between HTLV-1 Tax and I kappa B alpha is dependent on the I kappa B alpha phosphorylation state. Petropoulos L; Hiscott J Virology; 1998 Dec; 252(1):189-99. PubMed ID: 9875328 [TBL] [Abstract][Full Text] [Related]
20. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. Traenckner EB; Wilk S; Baeuerle PA EMBO J; 1994 Nov; 13(22):5433-41. PubMed ID: 7957109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]